Space Motion Sickness and Motion Sickness: Symptoms and Etiology

Montclair Stat University, Montclair, NJ, USA.
Aviation Space and Environmental Medicine (Impact Factor: 0.78). 07/2013; 84(7):716-21. DOI: 10.3357/ASEM.3449.2013
Source: PubMed

ABSTRACT The adverse symptoms of space motion sickness (SMS) have remained problematic since the beginning of manned spaceflight. Despite over 50 yr of research SMS remains a problem that affects about half of all space travelers during the first 24-72 h of a spaceflight. SMS has been treated as another form of motion sickness (MS) despite distinct differences in symptomology. In this review SMS and MS differences are examined and documented based on available data. Vestibular biomechanics that occur during weightlessness coupled with theoretical assertions regarding human evolution have led us to propose a two-component model of SMS. The first component involves conflicting sensory signals inherent to the otolith organs that occur during weightlessness. The second component is a bimodal conflict between the otoliths and semicircular canals that can occur during normal head movements in weightlessness. Both components may inadvertently, and mistakenly, signal that a vestibular malfunction has occurred, hence initiating a protective mechanism that may produce symptoms that discourage activity.

Download full-text


Available from: Frederick Bonato, Dec 18, 2013
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The purpose of this study was to investigate the microdialysis pharmacokinetic of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration. The pharmacokinetic study of subcutaneous and oral administration was also performed in rats. From the in vivo results, scopolamine intranasal administration can avoid hepatic first-pass effect. Tmax plasma samples after intranasal administration were significantly faster than oral administration and subcutaneous injection. The relative bioavailability of intranasal administrations was 51.8-70% when compared with subcutaneous injection. Moreover, one can see that in comparison with scopolamine subcutaneous administration, scopolamine intranasal gel and solutions can increased drug target index (DTI) with olfactory bulb 1.69 and 2.05, vestibule 1.80 and 2.15, respectively. The results indicated that scopolamine can be absorbed directly through the olfactory mucosa into the olfactory bulb, and then transported to various brain tissue after intranasal administration, with the characteristics of brain drug delivery.
    Drug Delivery 05/2014; DOI:10.3109/10717544.2014.910565 · 2.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Weerts AP, Vanspauwen R, Fransen E, Jorens PG, Van de Heyning PH, Wuyts FL. Space motion sickness countermeasures: a pharmacological double-blind, placebo-controlled study. Aviat Space Environ Med 2014; 85:638–44. Introduction: Space motion sickness (SMS), caused by a canal-otolith conflict, is currently treated with intramuscular promethazine. However, the drug has an inconsistent efficacy against SMS. We hypothesize that pharmacological depression of the semicircular canals (SCC) might relieve SMS. The aim of the present study was to identify the effects of meclizine (25 mg), dimenhydrinate (40 mg) combined with cinnarizine (25 mg), and promethazine (25 mg) combined with d-amphetamine (10 mg) on the SCCs and the otoliths. Methods: This double-blind, placebo-controlled study was performed on 20 healthy men. Function of the SCC was evaluated by means of an electronystagmography, whereas utricular function was assessed by a unilateral centrifugation test. A cervical vestibular evoked myogenic potentials test evaluated saccular function. Results: Meclizine (0.54 ± 0.05 vs. 0.38 ± 0.06) and dimenhydrinate with cinnarizine (0.54 ± 0.05 vs. 0.45 ± 0.05) decreased the vestibulo-ocular reflex gain. Promethazine with d-amphetamine decreased the latency of the saccadic eye response (right eye: 185 ± 3.8 ms vs. 165 ± 4.5 ms; left eye: 181 ± 4.9 ms vs. 165 ± 4.8 ms) and also increased the phase of ocular counterrolling measured during unilateral centrifugation (0.32 ± 0.35° vs. 1.5 ± 0.45°). Discussion: It is hypothesized that meclizine and dimenhydrinate with cinnarizine affect the medial vestibular nucleus. Promethazine is a vestibular suppressor, but study results show that d-amphetamine counterbalances this depression and abolishes the effect of fatigue on the saccadic reaction time The hypothesis that a SCC-suppression alleviates SMS should be further evaluated.
    Aviation Space and Environmental Medicine 06/2014; 85(6). DOI:10.3357/ASEM.3865.2014 · 0.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ability to maintain the body relative to the external environment is important for adaptation to altered gravity. However, the physiological limits for adaptation or the disruption of body orientation are not known. In this study, we analyzed postural changes in mice upon exposure to various low gravities. Male C57BL6/J mice (n = 6) were exposed to various gravity-deceleration conditions by customized parabolic flight-maneuvers targeting the partial-gravity levels of 0.60, 0.30, 0.15 and μ g (<0.001 g). Video recordings of postural responses were analyzed frame-by-frame by high-definition cineradiography and with exact instantaneous values of gravity and jerk. As a result, the coordinated extension of the neck, spine and hindlimbs was observed during the initial phase of gravity deceleration. Joint angles widened to 120%-200% of the reference g level, and the magnitude of the thoracic-curvature stretching was correlated with gravity and jerk, i.e., the gravity deceleration rate. A certain range of jerk facilitated mouse skeletal stretching efficiently, and a jerk of -0.3~-0.4 j (g/s) induced the maximum extension of the thoracic-curvature. The postural response of animals to low gravity may undergo differential regulation by gravity and jerk.
    06/2014; 4(2):174-88. DOI:10.3390/life4020174